Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease

Clinical and Experimental Allergy

Volumn 43, Issue 8, 2013, Pages 874-880

  Miller, B ^a   Mirakian, R ^b   Gane, S ^b   Larco, J ^b   Sannah, A A ^b   Darby, Y ^b   Scadding, G ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Auditory Biophysics Group   (United Kingdom)

Author keywords

Aspirin; Aspirin exacerbated respiratory disease; Asthma; Diagnosis; Nasal polyps

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; LYSINE; STEROID;

ACOUSTIC RHINOMETRY; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BRONCHOSPASM; CHEST TIGHTNESS; CHRONIC RHINOSINUSITIS; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PEAK NASAL INSPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RECURRENT DISEASE; STEROID THERAPY; UPPER RESPIRATORY TRACT OBSTRUCTION; URTICARIA;

ASPIRIN; ASPIRIN-EXACERBATED RESPIRATORY DISEASE; ASTHMA; DIAGNOSIS; NASAL POLYPS;

ADULT; AGED; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; FEMALE; HUMANS; LYSINE; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; REPRODUCIBILITY OF RESULTS; RHINITIS;

EID: 84881020322     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12110     Document Type: Article

References (20)

1. Stevenson D, Sanchez-Borges M, Szczekilik A. Classification of allergic and pseudo-allergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87:1-4.
2. Jenkins CH, Costello J, Hodge L. Systematic review of prevalence of aspirin- induced asthma and its implications for clinical practice. BMJ 2004; 328:434-40.
3. Jenneck C, Juergens U, Buecheler M, Novak N. Pathogenesis, diagnosis and treatment of aspirin intolerance. Allergy Asthma Immonol 2007; 99:13-21.
4. Kim JE, Kountakis SE. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery. Ear Nose Throat J 2007; 86:396-9.
5. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE investigators European Network on aspirin induced asthma. Eur Resp J 2000; 16:432-6.
6. Kowalski ML, Makowaska JS, Blanca M, Bavbek S, Bocheneck G, Bousquet J, et al. Hypersensitivity to NSAIDs-classification, diagnosis and management: review of the EAACI/ENDA and Ga2len/Hanna. Allergy 2011; 66:818-29.
7. Viola M, Rumi G, Valuzzi RL, Gaeta F, Caruso C, Romano A. Assessing potential determinants of positive provocation tests with NSAID hypersensititvity. Clin Exp Allergy 2010; 41:96-103.
8. Sánchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 2010; 94:853-64, xiii.
9. Hecksteden K, Schafer D, Stuck BA, Klimek L, Hormann K. Diagnosis of analgesic intolerance using a functional cell test ("analgesic intolerance test": AIT). Allergologie 2003; 26:263-71.
10. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:1111-8.
11. Barranco P, Bobolea I, Larco JL, Prior N, Lopez-Serrano MC, Quirche S. Diagnosis of aspirin induced asthma combining the bronchial and the oral challenge tests: a pilot study. J Investig Allergol Clin Immunol 2009; 19:446-52.
12. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101:581-6.
13. Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol 2000; 85:477-82.
14. Nathan RA, Eccles R, Howarth PH, Steinsvag SK, Togias A. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 2005; 115:S442-59.
15. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otol H & N Surg 1997; 117:S35-40.
16. Malm L, Gerth van Wijk R, Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology 2000; 38:1-6.
17. Holmström M, Scadding GK, Lund VJ, Darby YC. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990; 28:191-6.
18. Farhat DVN, Theodoratou E, Farrington SM, Tenesa A, et al. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 2010; 59:1670-9.
19. Cuzick J, Otto F, Baron JA, Brown PH, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10; 2009: 501-7.
20. Mita H, Higashi N, Tamiguchi M, Higashi A. Increased urinary leukotriene B4 glucuronide concentration in patients with aspirin intolerant asthma after intravenous aspirin challenge. Clin Exp Allergy 2004; 34:1262-9.